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Deep Brain Stimulation for Essential Tremor Refractory to Thalamotomy
Ashleigh Menhadji MD, Stanlies D'Souza MD
Department of Anesthesiology at Baystate Medical Center/University of Massachusetts Medical School

INTRODUCTION
Deep Brain Stimulation (DBS) is an accepted treatment for many psychiatric and neurologic disorders, including essential
tremor. The procedure has some distinct advantages over traditional surgical ablative procedures such as thalamotomy and
pallidotomy in that it is adjustable, reversible, and no tissue is destroyed in the process. The implanted device consists of
three components: 1) intracranial electrodes, 2) a single or dual chamber programmable internal pulse generator (IPG) with
battery, and 3) an extension cable that connects the two. The implantation procedure itself is staged with the first portion,
"awake brain surgery," involving placement of the electrodes in the target area of the brain and subcutaneous tunneling of the
extension cable from the electrodes to the site of the IPG. The second stage, usually a separate procedure from the first,
involves implanting the IPG device into the infraclavicular area.1

CASE DESCRIPTION
A 59-year-old right-handed woman with a
history of type II diabetes mellitus, bronchitis
and essential upper extremity tremors that
started when she was a teenager. She stated
that the tremors interfered with her ability to
perform her activities of daily living, including
drinking fluids without spilling, and writing. She
denied head or voice tremor. She tried multiple
medications with very minimal effect. She also
tried a left thalamotomy but reported that she
did not have any benefit of her right upper
extremity. So she presented for DBS. Patient
was anesthetized with dexmedetomidine bolus
and continuous infusion (0.2-0.5mcg/kg/hr),
propofol (30-80mcg/kg/min) and remifentanil
(0.01-0.03mcg/kg/min) infusions which were
titrated to effect before incision and weaned off
prior to anticipated wake-up. While awake,
patient was asked to complete tasks as
microelectrodes
stimulated
the
ventral
intermediate thalamus of the nucleus
bilaterally and tremor response was observed.
Patient remained awake for about 1.5 hrs for
correct positioning after which infusions were
restarted, patient went back to sleep and
electrodes were fixed into place.

DISCUSSION
Anesthesia for DBS is a challenge as a balance must be struck
between analgesia and preventing interference with brain
mapping and testing, all while preventing respiratory depression.
The ideal agents should not interfere with microelectrode
recording and testing and should have either no effect or an easily
reversible effect on subcortical neuronal activity. While the surgery
can be accomplished with either MAC or general anesthesia, MAC
is preferred and offers a few advantages over general. MAC
allows clinical symptoms like tremors to be evaluated during
surgery as certain brain structures are stimulated by the
electrodes. MAC also allows better control of patient
hemodynamics which is important since hypertension leading to
intracerebral hemorrhage is a potential complication of the
procedure. Benzodiazepines and high-dose opioids interfere with
microelectrode recording during stimulation testing, as subcortical
areas are sensitive to GABA medications. Short-acting opioids,
however, have little effect on microelectrode recording.2
During our case, we employed a combination of
dexmedetomidine, propofol and remifentanil as these drugs allow
for appropriate sedation, analgesia and blood pressure control but
are easily titratable to prevent respiratory depression. Propofol
and remifentanil can be run early during placement of stereotactic
head frame and stopped well before the macrostimulation phase
of surgery, given that they are short-acting, while
dexmedetomidine can be kept running as the patient is woken up
since it has no effect on microelectrode recording.3

CONCLUSION
Anesthesia for DBS presents a challenge for anesthesiologists as patients
must be appropriately sedated to comfortably undergo placement of
intracranial electrodes but must also be easy to arouse for the
macrostimulation phase of said electrodes so that they can be
appropriately placed for treatment. Short-acting opioids like remifentanyl
and the alpha-2 adrenergic agonist dexmedetomidine are good choices as
neither will affect microelectrode recording. Propofol can also be used for
portions of the procedure but should be appropriately timed to stop before
the macrostimulation phase.
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